Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-730P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[2][5]. Pseudogenes like RNU6-730P result from retrotransposition or genomic duplication events and are characterized by sequence similarity to parental snRNA genes but contain disabling mutations or truncations that prevent them from encoding a functional small nuclear RNA[2][5]. Functional U6 snRNA is an essential component of the spliceosome complex, crucial for pre-mRNA splicing in eukaryotes[1][3]. However, RNU6-730P itself is non-functional and generally does not contribute to splicing or other cellular processes[2][5]. Pseudogenes, including U6-derived ones, are widespread in the genome and can occasionally provide insight into genome evolution and the dynamics of retrotransposition but rarely have direct biological or clinical significance[2][4].
Not applicable (No known mechanisms, as this locus is a pseudogene and does not encode a functional RNA or protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 730, pseudogene (RNU6-730P).